Differences in Perception of Breast Cancer Treatment Between Patients, Physicians, and Nurses and Unmet Information Needs in Japan

Overview

Journal Support Care Cancer

Specialties Critical Care
Oncology

Date 2019 Sep 5

PMID 31482403

Citations 12

Authors

Haruna Sakai

Megumi Umeda

Hiromi Okuyama

Seigo Nakamura

Affiliations

Soon will be listed here.

Abstract

Purpose: Discrepancies exist between healthcare provider and patient perceptions surrounding breast cancer treatment. Significant treatment changes in the last 10 years have made re-evaluation of these perceptions necessary.

Methods: Physicians and nurses involved in breast cancer treatment, and patients who had received breast cancer chemotherapy (past 5 years), were questioned using an Internet survey. Participants ranked physical concerns (treatment side effects), psychological concerns, priorities for treatment selection, and side effects to be avoided during treatment. Patients were asked about desired treatment information/information sources. Rankings were calculated using the mean value of scores. Spearman's rank correlation was used to determine the concordance of rankings among groups.

Results: Survey respondents included 207 patients, 185 physicians, and 150 nurses. Patients and nurses similarly ranked distressing physical concerns; physician rankings differed. Quality of life (QoL) and treatment response ranked high with physicians and patients when considering future treatment; nurses prioritized QoL. All three groups generally agreed on ranking of psychological concerns experienced during chemotherapy, explanation of treatment options, and how treatment decisions were made, although more patients thought treatment decisions should be made independently. Healthcare providers reported providing explanations of treatment side effects and information on physical/psychological support options while patients felt both were lacking. Concordance was calculated as 0.47 (patient-physician), 0.83 (patient-nurse), and 0.76 (physician-nurse). Patients desired additional information, preferring healthcare providers as the source.

Conclusions: Specific areas for improvement in breast cancer patient care were identified; programs should be implemented to address unmet needs and improve treatment in these areas.

Citing Articles

Leveraging Large Language Models for Improved Understanding of Communications With Patients With Cancer in a Call Center Setting: Proof-of-Concept Study.

Cho S, Lee M, Yu J, Yoon J, Choi J, Jung K J Med Internet Res. 2024; 26:e63892.

PMID: 39661975 PMC: 11669882. DOI: 10.2196/63892.

Survey on adverse events associated with drug therapy for breast cancer patients.

Hara F, Nagasaki R, Minami R, Izutani T, Yoshida T, Arai A BMC Womens Health. 2024; 24(1):545.

PMID: 39363303 PMC: 11447999. DOI: 10.1186/s12905-024-03355-x.

Patient Preferences Influencing Treatment Decision-Making in Early-Stage Breast Cancer in Germany, Italy, and Japan.

Flood E, McCutcheon S, Beusterien K, Mackie D, Mokiou S, Guillaume X Patient Prefer Adherence. 2024; 18:1517-1530.

PMID: 39081589 PMC: 11287371. DOI: 10.2147/PPA.S450316.

Cross-sectional study of therapy-related expectations/concerns of patients with metastatic renal cell carcinoma and physicians in Japan.

Kimura G, Fujii Y, Osawa T, Uchitomi Y, Honda K, Kondo M Cancer Med. 2024; 13(11):e7196.

PMID: 38872405 PMC: 11176571. DOI: 10.1002/cam4.7196.

Long-term Experience on Breast Cancer-related Lymphedema in the Coastal Area of Fukushima, Japan After the 2011 Triple Disaster.

Kobayashi N, Ozaki A, Kotera Y, Kaneda Y, Bhandari D, Takamatsu K In Vivo. 2023; 38(1):272-280.

PMID: 38148086 PMC: 10756475. DOI: 10.21873/invivo.13435.

References

Cheung Y, Ong Y, Ng T, Tan Y, Fan G, Chan C . Assessment of mental health literacy in patients with breast cancer. J Oncol Pharm Pract. 2015; 22(3):437-47. DOI: 10.1177/1078155215587541. View

Wolff A, Hammond M, Allison K, Harvey B, Mangu P, Bartlett J . Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. Arch Pathol Lab Med. 2018; 142(11):1364-1382. DOI: 10.5858/arpa.2018-0902-SA. View

Ahern T, Gardner A, Courtney M . Exploring patient support by breast care nurses and geographical residence as moderators of the unmet needs and self-efficacy of Australian women with breast cancer: Results from a cross-sectional, nationwide survey. Eur J Oncol Nurs. 2016; 23:72-80. DOI: 10.1016/j.ejon.2016.05.001. View

Schmidt A, Ernstmann N, Wesselmann S, Pfaff H, Wirtz M, Kowalski C . After initial treatment for primary breast cancer: information needs, health literacy, and the role of health care workers. Support Care Cancer. 2015; 24(2):563-571. DOI: 10.1007/s00520-015-2814-6. View

Halbach S, Enders A, Kowalski C, Pfortner T, Pfaff H, Wesselmann S . Health literacy and fear of cancer progression in elderly women newly diagnosed with breast cancer--A longitudinal analysis. Patient Educ Couns. 2016; 99(5):855-62. DOI: 10.1016/j.pec.2015.12.012. View

Harding V, Afshar M, Krell J, Ramaswami R, Twelves C, Stebbing J . 'Being there' for women with metastatic breast cancer: a pan-European patient survey. Br J Cancer. 2013; 109(6):1543-8. PMC: 3777001. DOI: 10.1038/bjc.2013.492. View

Dean L, Moss S, McCarthy A, Armstrong K . Healthcare System Distrust, Physician Trust, and Patient Discordance with Adjuvant Breast Cancer Treatment Recommendations. Cancer Epidemiol Biomarkers Prev. 2017; 26(12):1745-1752. PMC: 5712243. DOI: 10.1158/1055-9965.EPI-17-0479. View

Mori M, Shimizu C, Ogawa A, Okusaka T, Yoshida S, Morita T . A National Survey to Systematically Identify Factors Associated With Oncologists' Attitudes Toward End-of-Life Discussions: What Determines Timing of End-of-Life Discussions?. Oncologist. 2015; 20(11):1304-11. PMC: 4718424. DOI: 10.1634/theoncologist.2015-0147. View

Mulders M, Vingerhoets A, Breed W . The impact of cancer and chemotherapy: perceptual similarities and differences between cancer patients, nurses and physicians. Eur J Oncol Nurs. 2008; 12(2):97-102. DOI: 10.1016/j.ejon.2007.10.002. View

10.

Hong J, Song Y, Liu J, Wang W, Wang W . Perception and fulfillment of cancer patients' nursing professional social support needs: from the health care personnel point of view. Support Care Cancer. 2013; 22(4):1049-58. DOI: 10.1007/s00520-013-2062-6. View

11.

Vaz-Luis I, ONeill A, Sepucha K, Miller K, Baker E, Dang C . Survival benefit needed to undergo chemotherapy: Patient and physician preferences. Cancer. 2017; 123(15):2821-2828. PMC: 5517352. DOI: 10.1002/cncr.30671. View

12.

Rugo H, Klein P, Melin S, Hurvitz S, Melisko M, Moore A . Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer. JAMA. 2017; 317(6):606-614. PMC: 5639721. DOI: 10.1001/jama.2016.21038. View

13.

Miyashita M, Ohno S, Kataoka A, Tokunaga E, Masuda N, Shien T . Unmet Information Needs and Quality of Life in Young Breast Cancer Survivors in Japan. Cancer Nurs. 2014; 38(6):E1-11. PMC: 4612149. DOI: 10.1097/NCC.0000000000000201. View

14.

Nozawa K, Shimizu C, Kakimoto M, Mizota Y, Yamamoto S, Takahashi Y . Quantitative assessment of appearance changes and related distress in cancer patients. Psychooncology. 2013; 22(9):2140-7. DOI: 10.1002/pon.3268. View

15.

Lin J, Chao J, Bickell N, Wisnivesky J . Patient-provider communication and hormonal therapy side effects in breast cancer survivors. Women Health. 2016; 57(8):976-989. PMC: 6149211. DOI: 10.1080/03630242.2016.1235071. View

16.

Katanoda K, Matsuda T . Five-year relative survival rate of breast cancer in the USA, Europe and Japan. Jpn J Clin Oncol. 2014; 44(6):611. DOI: 10.1093/jjco/hyu073. View